Lygos, Inc., a Berkeley, CA-based bio-based specialty chemicals company, closed a $13m Series A financing.
The round was led by IA Ventures and OS Fund with participation from First Round Capital, the Y Combinator Continuity Fund, 50 Years and Vast Ventures, along with angel investors.
The company intends to use the funds to continue building the team and increase its manufacturing efforts.
Founded by Jeffrey Dietrich, Clem Fortman, Jay Keasling, Leonard Katz, and Eric Steen out of U.C. Berkeley Labs in 2010, Lygos creates microbial-based manufacturing solutions combining biology and technology. Its firs tproduct is the Bio-malonic™ acid-producing microbes that are a replacement for the dangerous cyanide-based process that manufacturers currently use in the market.